Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
16,19 USD | +0,81% | +3,19% | -9,81% |
Métier
Nombre d'employés: 344
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Gene Therapy
100,0
%
| 113 | 100,0 % | 90 | 100,0 % | -19,94% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
International
68,0
%
| 62 | 55,0 % | 61 | 68,0 % | -1,02% |
United States
32,0
%
| 39 | 35,0 % | 29 | 32,0 % | -26,81% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Kenneth Mills
FOU | Founder | 49 | 16/07/08 |
Vit Vasista
DFI | Director of Finance/CFO | 56 | 01/08/09 |
Chief Tech/Sci/R&D Officer | - | 01/11/15 | |
Olivier Danos
CTO | Chief Tech/Sci/R&D Officer | 66 | 28/03/17 |
Stephen Pakola
CTO | Chief Tech/Sci/R&D Officer | 55 | 17/04/19 |
Curran Simpson
COO | Chief Operating Officer | 62 | 01/08/15 |
Shiva G. Fritsch
IRO | Public Communications Contact | - | 01/01/17 |
Laura Coruzzi
PRN | Corporate Officer/Principal | 71 | - |
Ram Palanki
PRN | Corporate Officer/Principal | 48 | 01/08/18 |
General Counsel | 53 | 01/08/16 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
George Migausky
BRD | Director/Board Member | 69 | 03/09/21 |
David Stump
BRD | Director/Board Member | 74 | 15/10/15 |
Director/Board Member | 71 | 01/05/15 | |
Daniel Tassé
BRD | Director/Board Member | 64 | 15/08/16 |
Director/Board Member | 65 | 25/05/18 | |
Allan Fox
CHM | Chairman | 76 | 01/01/09 |
Kenneth Mills
FOU | Founder | 49 | 16/07/08 |
Jennifer Zachary
BRD | Director/Board Member | 46 | 03/06/22 |
Jean Bennett
BRD | Director/Board Member | 69 | 01/03/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 49 042 717 | 45 180 406 ( 92,12 %) | 0 | 92,12 % |
Coordonnées société
Secteur
Ventes par région
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-9,81% | 794 M | |
-2,31% | 103 Md | |
+0,56% | 95,28 Md | |
+1,69% | 22,15 Md | |
-17,37% | 21,02 Md | |
-9,30% | 18,15 Md | |
-41,01% | 16,73 Md | |
-14,85% | 16,05 Md | |
+3,21% | 13,68 Md | |
+33,54% | 12,17 Md |
- Bourse
- Actions
- Action RGNX
- Société REGENXBIO Inc.